These results show a lineage-specific role for SMARCB1 in vitro, validating recently developed MRT GEMMs wherein Smarcb1 loss-induced rhabdoid tumor development was demonstrated to be limited to a specific developmental time and lineage (Han et al., 2016; Vitte et al., 2017). This evidence concerns the gene SMARCB1 and rhabdoid tumor.